Pyxis Oncology, Inc. (PYXS)
USD 1.52
(-6.75%)
USD 1.52
(-6.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -70.7 Million | -89.33 Million | -35.32 Million | -10.08 Million | -2.23 Million |
| Net Income | -73.79 Million | -120.71 Million | -75.97 Million | -12.82 Million | -2.77 Million |
| Depreciation & Amortization | 2 Million | 709 Thousand | 647 Thousand | 469 Thousand | - |
| Deferred income taxes | 3.5 Million | - | 6.28 Million | - | - |
| Stock-based compensation | 16.94 Million | 15.76 Million | 6.44 Million | 44 Thousand | 28 Thousand |
| Change in working capital | -11.66 Million | 4.5 Million | 6.67 Million | 2.28 Million | 505 Thousand |
| Other non-cash items | -7.7 Million | 10.4 Million | 20.6 Million | -56 Thousand | -264 Thousand |
| Investing Cash Flow | -104.84 Million | -6.39 Million | -590 Thousand | -1.48 Million | - |
| Investments in PPE | -6.72 Million | -6.39 Million | -540 Thousand | -1.48 Million | - |
| Acquisitions | 6.66 Million | - | -50 Thousand | - | - |
| Investment purchases | -196.83 Million | - | -50 Thousand | - | - |
| Sales/Maturities of investments | 92.04 Million | - | 50.05 Thousand | - | - |
| Other Investing Activities | -104.78 Thousand | - | -50.00 | - | - |
| Financing Cash Flow | 5.92 Million | 183 Thousand | 304.04 Million | 35 Thousand | 21.95 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -445.00 | - | - | - | - |
| Common Stock Issuance | 6.37 Million | 183 Thousand | 152.29 Million | 35 Thousand | 13 Thousand |
| Other Financing Activities | -445 Thousand | 183.00 | 151.74 Million | 35.00 | 21.94 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -3.5 Million | -8.32 Million | 4.64 Million | 558 Thousand | 292 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -8.15 Million | 12.82 Million | 2.03 Million | 1.72 Million | 213 Thousand |
| Cash at beginning of period | 180.76 Million | 276.31 Million | 8.18 Million | 19.72 Million | 4000.00 |
| Cash at end of period | 11.13 Million | 180.76 Million | 276.31 Million | 8.18 Million | 19.72 Million |
| Capital Expenditure | -6.72 Million | -6.39 Million | -540 Thousand | -1.48 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -169.62 Million | -95.55 Million | 268.12 Million | -11.53 Million | 19.71 Million |
| Free Cash Flow | -77.43 Million | -95.73 Million | -35.86 Million | -11.56 Million | -2.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.3 Million | -3.25 Million | -15.59 Million | -73.79 Million | -23.04 Million | -15.9 Million |
| Depreciation & Amortization | 585 Thousand | 1.11 Million | 763 Thousand | 2 Million | 523 Thousand | 524 Thousand |
| Deferred income taxes | - | - | -4.39 Million | 3.5 Million | -1.48 Million | -1.26 Million |
| Stock-based compensation | 2.87 Million | 4.32 Million | 3.21 Million | 16.94 Million | 5.17 Million | 3.66 Million |
| Change in working capital | 12.36 Million | -21.76 Million | -2.3 Million | -11.66 Million | 1.09 Million | 1.76 Million |
| Other non-cash items | -601 Thousand | 14.79 Million | 3.06 Million | -7.7 Million | 154 Thousand | 175 Thousand |
| Investing Cash Flow | 4000.00 | -18.49 Million | 10.22 Million | -104.84 Million | 6.57 Million | -22.25 Million |
| Investments in PPE | - | -237 Thousand | - | -6.72 Million | -61 Thousand | -2.25 Million |
| Acquisitions | - | - | 1000.00 | 6.66 Million | 6.65 Million | -15.19 Million |
| Investment purchases | -39.31 Million | -92.79 Million | -10.22 Million | -196.83 Million | -56.42 Million | -35.18 Million |
| Sales/Maturities of investments | 39.31 Million | 74.53 Million | 20.45 Million | 92.04 Million | 56.4 Million | 15.19 Million |
| Other Investing Activities | 4000.00 | -18.26 Million | 10.22 Thousand | -104.78 Thousand | -27.00 | 15.19 Million |
| Financing Cash Flow | 48 Thousand | 57.51 Million | -25 Thousand | 5.92 Million | -171 Thousand | 6.12 Million |
| Debt repayment | -62 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -43 Thousand | -196 Thousand | -52.00 | -445.00 | -393.00 | - |
| Common Stock Issuance | 153 Thousand | 57.7 Million | 27 Thousand | 6.37 Million | 222 Thousand | 6.12 Million |
| Other Financing Activities | -43 Thousand | -196 Thousand | -52 Thousand | -445 Thousand | -393 Thousand | 6125.00 |
| Accounts receivables | 8 Million | -8 Million | - | - | - | - |
| Accounts payables | 3.17 Million | -1.36 Million | 350 Thousand | -3.5 Million | -1.54 Million | -1.56 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.18 Million | -12.4 Million | -2.65 Million | -8.15 Million | 2.63 Million | 3.32 Million |
| Cash at beginning of period | 29.43 Million | 11.13 Million | 16.18 Million | 180.76 Million | 27.37 Million | 54.53 Million |
| Cash at end of period | 26.54 Million | 29.43 Million | 11.13 Million | 11.13 Million | 16.18 Million | 27.37 Million |
| Capital Expenditure | - | -237 Thousand | - | -6.72 Million | -61 Thousand | -2.25 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.89 Million | 18.3 Million | -5.05 Million | -169.62 Million | -11.18 Million | -27.16 Million |
| Free Cash Flow | -2.94 Million | -20.94 Million | -15.25 Million | -77.43 Million | -17.64 Million | -13.29 Million |
I3E
JETR
RBW
TECK-B
DRTSW
MMMW